COVID infection study in hospital staff withdrawn before start
NCT ID NCT04362267
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to track how many healthcare workers at Lille University Hospital caught COVID-19 over 10 weeks. Researchers planned to test 100 workers every two weeks using nasal swabs and blood tests, along with questionnaires about their work and home exposures. The goal was to understand infection patterns and improve safety measures. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Started
-
Jun 2020
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Health Care workers exposed to covid occupational exposure
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Health Care workers with covid high exposure during the care activities Exclusion Criteria: * Heath Care Worker with SARS-Cov2 infection ( RT-PCR +) or SARS-Cov2 immunity in serological testing * HCW off work * Subjects on leave
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Claude Huriez, CHU
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield lungs from COVID-19's worst damage?
- French ICU study reveals COVID-19 patient outcomes
- Massive study reveals COVID-19 risks for autoimmune patients
- Can early COVID-19 drugs keep high-risk patients out of the hospital?
- COVID-19 ICU patients may face higher superbug risk
- Could a single X-Ray tame COVID-19 lung inflammation?